Nerve Sparing Versus Non Nerve Sparing Robot-assisted Radical Cystectomy-orthotopic Ileal Neobladder for Bladder Cancer in the Male
- Conditions
- Bladder Cancer
- Interventions
- Procedure: nerve sparing
- Registration Number
- NCT05018429
- Brief Summary
To compare the perioperative, functional, and oncologic outcomes between non nerve sparing and nerve sparing robot-assisted radical cystectomy with orthotopic ileal neobladder in male patients with bladder cancer.
- Detailed Description
This study will enroll male patients with bladder cancer who will undergo robot-assisted radical cystectomy with orthotopic ileal neobladder. The patients will be distributed into two comparable groups according to surgical procedures: non nerve sparing group and nerve sparing group. Patient demographic and pathologic, perioperative, functional, and oncologic outcomes will be compared between the two groups.
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- Male
- Target Recruitment
- 100
- Male patients aged 18 or older.
- Patients those who are diagnosed with urothelial carcinoma.
- Patients those who are capable of receiving radical cystectomy with orthotopic ileal neobladder.
- Patients those who are able to cooperate and complete the follow-up.
- Patients those who volunteer to participate in this study and sign the informed consens.
- Patients thsoe who are diagnosed distant metastasis before surgery.
- Patients those who are diagnosed with other malignancies.
- Patients those who had received pelvic radiotherapy or major pelvic operation.
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Arm && Interventions
Group Intervention Description nerve sparing group nerve sparing Patients will be preverved the neurovascular bundles during the resection of bladder and prostate of the operation.
- Primary Outcome Measures
Name Time Method day-time continence rate 6 months Patients were considered continent when they required 0 or 1 safety pad during the day-time.
night-time continence rate 6 months Patients were considered continent when they required 0 or 1 safety pad during the night.
postoperative sexual function 6 months The sexual function are evaluated by the International Index of Erectile Function-5 (IIEF-5).
- Secondary Outcome Measures
Name Time Method perioperative complication rate 3 months recurrence-free survival 1 year estimated blood loss 24 hours operative time 24 hours overall survival 1 year
Trial Locations
- Locations (1)
Sun Yat-sen Memorial Hospital, Sun Yat-sen University
🇨🇳Guangzhou, Guangdong, China